HomeNewsPiramal lifesciences

Piramal Lifesciences

Jump to

Piramal Life falls 91% on demerger of NCE Research unit

Piramal Lifesciences fell 91% on the boures today as it demerged NCE Research unit into Piramal Healthcare (PHL). At 14:35 hours IST, the share was trading at Rs 8.80.
Elara's take on top pharma stocks: Ranbaxy, DRL, Cipla

Surajit Pal, Pharma Analyst at Elara Capital, in an interview with CNBC-TV18's Latha Venkatesh and Sonia Shenoy, spoke about his reading of the pharma sector and his outlook on a few stocks.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Piramal Lifesciences

Piramal Life falls 91% on demerger of NCE Research unit

Elara's take on top pharma stocks: Ranbaxy, DRL, Cipla